Three top executives at Viking Therapeutics (CEO, CFO, COO) collectively sold $6.27M in stock on the same day (July 29, 2026), representing ~0.16% of the company's $3.9B market cap. While the dollar amount is modest relative to market cap, the cluster of C-suite insiders selling simultaneously warrants attention, though the signal is weakened by the academic literature showing cluster sales are not reliably informative.
VKTX drugs
VKTX drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 30 $33.11entry
- T+1 · 4mo ago −4.14%α −4.86% · $31.74
- T+5 · 3mo ago +0.57%α −3.05% · $33.30
- T+20 · 3mo ago +2.27%α −1.70% · $33.86
- T+60 · 25d ago −26.31%α −28.77% · $24.40
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three top executives at Viking Therapeutics (CEO, CFO, COO) collectively sold $6.27M in stock on the same day (July 29, 2026), representing ~0.16% of the company's $3.9B market cap. While the dollar amount is modest relative to market cap, the cluster of C-suite insiders selling simultaneously warrants attention, though the signal is weakened by the academic literature showing cluster sales are not reliably informative.
Key Financial Metrics
Key Facts
- CEO Lian Brian sold 148.5K shares for $4.95M on July 29, 2026
- CFO Zante Greg sold 21.2K shares for $710K on same day
- COO Mancini Marianna sold 18.2K shares for $610K on same day
- Total insider sales of $6.27M represent ~0.16% of VKTX's $3.9B market cap
- All three sales occurred on the same date, suggesting possible 10b5-1 plan or blackout window opening
Financial Impact
Total insider sales of $6.27M, or ~0.16% of market cap, modest and routine in magnitude
Risk Factors
- Insider sales may be liquidity-driven or part of pre-arranged 10b5-1 plans, not a bearish signal
- No earnings or press release context provided to link sales to a specific catalyst
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-VKTX-1786169041524 |
Track record
13 reports on VKTX
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +31.38% at T+20 after the Sep 24, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $25.79 to $26.84 Now $26.80 +3.92% ▲ +4.07% +3.76% vs SPY
- Oct 28, 202619d ago 8-K Neutral 5/10 Entry $26.86 to $27.28 Now $26.80 −0.22% ▲ +1.56% +3.34% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $24.40 to $24.21 Now $26.80 −9.84% ▲ +0.78% +1.49% vs SPY
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $25.83 to $24.40 Now $26.80 +3.76% ▼ −5.54% −5.01% vs SPY
- Sep 28, 20267w ago 8-K Mixed 6/10 Entry $31.81 to $32.60 Now $26.80 −15.75% ▲ +2.48% +2.69% vs SPY
- Sep 24, 20267w ago 424B5 Bearish 5/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
- Sep 24, 20267w ago 424B5 Bearish 6/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
- Sep 23, 20267w ago 424B5 Neutral 4/10 Entry $36.75 to $35.56 Now $26.80 −27.07% ▼ −3.24% −3.78% vs SPY
- Sep 23, 20267w ago 424B5 Bearish 6/10 Entry $36.75 to $35.56 Now $26.80 +27.07% ▲ +3.24% +3.78% vs SPY
- Sep 22, 20267w ago 8-K Bullish 7/10 Entry $40.85 to $41.65 Now $26.80 −34.39% ▲ +1.96% +2.68% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers